Literature DB >> 3856007

Collagen sponge as a topical hemostatic agent in mucogingival surgery.

M D Stein, L M Salkin, A L Freedman, V Glushko.   

Abstract

Hemorrhage from palatal donor sites during periodontal mucogingival surgery was controlled by application of Collastat absorbable hemostatic sponges. The use of collagen sponges was evaluated in 20 free-graft cases. In contrast to microfibrillar collagen, which is normally delivered as clumps of material, a Collastat sponge was applied as a single piece that maintained structural integrity even when wet and was easy to maneuver into place. The highly porous sponges conformed to the wound, absorbed fluid and produced consistently reliable hemostasis with no secondary bleeding. By stemming the seepage of blood into the throat, patient safety and comfort were improved. The sponges were left on the wounds and removed at the 1-week postoperative visit, revealing well-formed granulation tissue. Healing proceeded normally with no evidence of infection, tissue reaction, or other adverse effects.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3856007     DOI: 10.1902/jop.1985.56.1.35

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  4 in total

1.  The in vitro assessment of a collagen/vicryl (polyglactin) composite film together with candidate suture materials for use in urinary tract surgery. I. Physical testing.

Authors:  S D Gorham; M J Monsour; R Scott
Journal:  Urol Res       Date:  1987

Review 2.  Biologic response of local hemostatic agents used in endodontic microsurgery.

Authors:  Youngjune Jang; Hyeon Kim; Byoung-Duck Roh; Euiseong Kim
Journal:  Restor Dent Endod       Date:  2014-03-21

3.  A novel design of palatal stent to reduce donor site morbidity in periodontal plastic surgery.

Authors:  Tzu-Shan Chiu; Huan-Cheng Chou; Po-Jan Kuo; Jia-Yuan Liang; Hsien-Chung Chiu
Journal:  J Dent Sci       Date:  2020-04-18       Impact factor: 2.080

4.  Efficacy of topical application of beta urogastrone (recombinant human epidermal growth factor) in Wagner's Grade 1 and 2 diabetic foot ulcers: Comparative analysis of 50 patients.

Authors:  Sanjeev Singla; Ramneesh Garg; Abhishek Kumar; Chiranjiv Gill
Journal:  J Nat Sci Biol Med       Date:  2014-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.